Belen Perez,
Has a PhD in Biological Sciences (1994) from the Autonomous University of Madrid (UAM). She is a Full Professor of the Department of Molecular Biology at the UAM, where she teaches Human Genetics, Genetic Engineering, and Biochemistry. Belen Pérez is a molecular geneticist involved in the biochemical and genetic diagnostics of inherited metabolic diseases. She is the deputy director of the Center for Diagnosis of Molecular Diseases (CEDEM) and the head of a group on CIBER Rare Diseases at the Biomedical Research Institute (IdiPAZ). She has a research line titled "Translational medicine in inborn errors of metabolism and other rare genetic diseases." at the Center of Molecular Biology (CBM-UAM-CSIC).
The activity of her group is aimed at transferring knowledge on rare diseases to the clinical practice to advance in the incorporation of novel and cutting-edge methods for diagnosis, prevention, and therapies through the combination of multi-omic layers (genomic, transcriptomic, epigenomics, and metabolomic) with functional and structural genomics. Finally, the group is interested in developing therapeutic strategies targeted at the mechanism of action of the variants identified in neurometabolic diseases in the era of personalized medicine, specifically in developing pharmacological chaperones, mRNA therapies, or gene editing. She is author of more than 190 papers in high impact factor international journals (ORCID 0000-0002-3190-1958).